SIREN : 520225202
PROMEDIC is a French company founded 16 years ago, specialized in the sector Activités des sociétés holding. Based in BOULOGNE-BILLANCOURT (92100), this company of category PME shows in 2024 a net income positive of 219 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2017 |
|---|---|---|
| Revenue | N/C | N/C |
| Net income | 219 029 € | -11 932 € |
| EBITDA | -6 496 € | -11 434 € |
| Net margin | N/C | N/C |
In 2024, PROMEDIC generates positive net income of 219 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
-6 496 €
-6 495 €
219 029 €
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 0%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
0.0%
0.0%
0.0
In 2024, the debt ratio of PROMEDIC (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
In 2024, the financial autonomy of PROMEDIC (0.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2024, the repayment capacity of PROMEDIC (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 312.74. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
312.743
0.0
In 2024, the liquidity ratio of PROMEDIC (312.74) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2024, the interest coverage of PROMEDIC (0.0x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Based on 54 transactions of similar company sales
in 2024,
the value of PROMEDIC is estimated at
319 774 €
(range 203 946€ - 1 635 809€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 54 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare PROMEDIC with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des sociétés holding
The revenue of PROMEDIC is not publicly disclosed (confidential accounts filed with INPI).
Yes, PROMEDIC generated a net profit of 219 k€ in 2024.
The headquarters of PROMEDIC is located in BOULOGNE-BILLANCOURT (92100), in the department Hauts-de-Seine.
The tax return of PROMEDIC is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
PROMEDIC operates in the sector Activités des sociétés holding (NAF code 64.20Z). See the 'Sector positioning' section above to compare the company with its competitors.